Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6

Competitive endogenous RNA in colorectal cancer: A systematic review

(2018) Han Shuwen et al.   GENE

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

(2017) Nene N. Kalu et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Blocking the Cycle: Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic, Hormone Receptor–Positive Breast Cancer

(2017) Seth A. Wander et al.   JOURNAL OF CLINICAL ONCOLOGY

Cell-Cycle Therapeutics Come of Age

(2017) Matthew Ingham et al.   JOURNAL OF CLINICAL ONCOLOGY

MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma

(2017) Matias A. Bustos et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Circular RNAs in cancer: opportunities and challenges in the field

(2017) L S Kristensen et al.   ONCOGENE

Treating cancer with selective CDK4/6 inhibitors

(2016) Ben O'Leary et al.   Nature Reviews Clinical Oncology

Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future

(2016) Adam J. DiPippo et al.   PHARMACOTHERAPY

CircNet: a database of circular RNAs derived from transcriptome sequencing data

(2015) Yu-Chen Liu et al.   NUCLEIC ACIDS RESEARCH

Targeting CDK4 and CDK6: From Discovery to Therapy

(2015) C. J. Sherr et al.   Cancer Discovery

Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition

(2014) Liping Sun et al.   PLoS One

Co-Expression of XIAP and Cyclin D1 Complex Correlates with a Poor Prognosis in Patients with Hepatocellular Carcinoma

(2012) Yufang Che et al.   AMERICAN JOURNAL OF PATHOLOGY

Rb inactivation in cell cycle and cancer: The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase

(2011) Sabine Paternot et al.   CELL CYCLE

Racing to block tumorigenesis after pRb loss: An innocuous point mutation wins with synthetic lethality

(2010) Frederick Bauzon et al.   CELL CYCLE

Epigenetic regulation of theINK4b-ARF-INK4alocus

(2010) Nikolay Popov et al.   Epigenetics